Andrea A Bacigalupo

Sort by:

Defining the intensity of conditioning regimens: working definitions.

Andrea A Bacigalupo, Karen Kuhn Ballen, +11 authors Mary Horowitz
Biology of blood and marrow transplantation…
2009

Defining conditioning regimen intensity has become a critical issue for the hemopoietic stem cell transplant (HSCT) community. In the present report we propose to define conditioning regimens in 3… (More)

Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia.

Stefan O Ciurea, Mei-Jie Zhang, +23 authors Mary Eapen
Blood
2015

We studied adults with acute myeloid leukemia (AML) after haploidentical (n = 192) and 8/8 HLA-matched unrelated donor (n = 1982) transplantation. Haploidentical recipients received calcineurin… (More)

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

Andrea A Bacigalupo, Teresa Lamparelli, +9 authors Alberto Bosi
Blood
2001

One hundred nine patients with hematologic malignancies, undergoing bone marrow transplants (BMT) from unrelated donors, were randomized in 2 consecutive trials to receive or not to receive… (More)

Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts.

Anna Maria Raiola, Alida Dominietto, +12 authors Andrea A Bacigalupo
Biology of blood and marrow transplantation…
2014

We studied 459 consecutive patients with hematologic malignancies, median age 44 years (range, 15 to 71 years), who underwent transplantation with grafts from identical sibling donors (SIB; n = 176),… (More)

Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated…

Andrea A Bacigalupo, Teresa Lamparelli, +9 authors Alberto Bosi
Biology of blood and marrow transplantation…
2006

This is an update of a randomized study on antithymocyte globulin (ATG; Thymoglobulin) before transplantation in patients undergoing unmanipulated marrow transplantation from unrelated donors. The… (More)

Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party.

Andrea A Bacigalupo, Jill M Hows, +7 authors Shaun McCann
British journal of haematology
1988

This is an analysis of 509 patients with severe aplastic anaemia (SAA) treated in Europe between 1981 and 1986; 218 patients were treated by allogeneic bone marrow transplantation (BMT) from HLA… (More)

Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood…

Andrea A Bacigalupo, Barbara Bruno, +13 authors Alice Ferster
Blood
2000

One hundred consecutive patients with severe aplastic anemia (SAA) received horse antilymphocyte globulin (ALG), cyclosporin A (CyA), 6-methylprednisolone (6Mpred), and granulocyte colony-stimulating… (More)

Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study…

Andrea A Bacigalupo, Gerard Socie', +10 authors Jacob R Passweg
Haematologica
2010

BACKGROUND We analyzed the outcome of 100 patients with acquired severe aplastic anemia undergoing an alternative donor transplant, after immune suppressive therapy had failed. DESIGN AND METHODS… (More)

Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party.

Andrea A Bacigalupo, Giorgio Broccia, +7 authors Giuseppe Todeschini
Blood
1995

Patients with severe aplastic anemia (SAA) and a neutrophil (PMN) count of less than 0.5 x 10(9)/L are exposed to a high risk of early mortality when treated with antilymphocyte globulin (ALG) and… (More)

Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups.

Andrea A Bacigalupo, Gerard J Socié, +12 authors Judith C. W. Marsh
Haematologica
2012

BACKGROUND Bone marrow has been shown to be superior to peripheral blood, as a stem cell source, in young patients (<20 years of age) with acquired aplastic anemia undergoing a matched sibling… (More)

Filter Results:

Publication Year

Publication Type

Co-author

Journals and Conferences